Haemophagocytic Lymphohistiocytosis as a Complication of Israeli Spotted Fever

Maria Margarida Andrade1, Ana Gorgulho1, Rita Tinoco Magalhães1

  • 1Internal Medicine Department, Hospital de Cascais Dr. José de Almeida, Alcabideche, Portugal.

Insights

Israeli spotted fever (ISF) can rarely cause haemophagocytic lymphohistiocytosis (HLH). This case highlights the need for early diagnosis and intervention for this severe complication of rickettsiosis.

Area of Science:

  • Infectious Diseases
  • Hematology
  • Immunology

Background:

  • Rickettsia spp. infections, including Mediterranean spotted fever and Israeli spotted fever (ISF), are endemic in Portugal.
  • Haemophagocytic lymphohistiocytosis (HLH) is a rare but severe condition characterized by excessive immune activation.

Purpose of the Study:

  • To describe a rare case of HLH secondary to ISF.
  • To emphasize the atypical clinical manifestations of ISF-induced HLH.
  • To highlight the importance of early clinical suspicion and intervention.

Main Methods:

  • Case report detailing clinical presentation, diagnostic workup, and management.
  • Review of literature on rickettsiosis and HLH.

Main Results:

  • A patient presented with atypical manifestations of ISF leading to HLH.
  • The case underscores the potential for severe, multisystemic complications from rickettsial infections.

Conclusions:

  • HLH is a rare but critical complication of rickettsiosis.
  • Suspicion for HLH should be raised in cases of rickettsiosis with exuberant inflammatory responses and multisystemic dysfunction.
  • Prompt diagnosis and supportive care are crucial for managing ISF-induced HLH, especially with severe cutaneous and neurological involvement.